Arachchige N, Sirisena N, De Silva S, Senathilake K, Faizan M, Dissanayake V
Hum Genomics. 2025; 19(1):12.
PMID: 39940038
PMC: 11823233.
DOI: 10.1186/s40246-024-00703-8.
Xia Y, Huang C, Zhong M, Zhong H, Ruan R, Xiong J
Cell Commun Signal. 2025; 23(1):46.
PMID: 39856684
PMC: 11762533.
DOI: 10.1186/s12964-025-02033-1.
Jackel E, Lazzeri G, Covino R
J Phys Chem B. 2025; 129(5):1586-1596.
PMID: 39848609
PMC: 11808646.
DOI: 10.1021/acs.jpcb.4c05242.
Gallo S, Folco C, Crepaldi T
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598385
PMC: 11597589.
DOI: 10.3390/ph17111473.
Chen Y, Morihiro K, Nemoto Y, Ichimura A, Ueki R, Sando S
Chem Sci. 2024; .
PMID: 39355222
PMC: 11440363.
DOI: 10.1039/d4sc04424j.
MET Oncogene Targeting for Cancer Immunotherapy.
Lombardi A, Sangiolo D, Vigna E
Int J Mol Sci. 2024; 25(11).
PMID: 38892318
PMC: 11173045.
DOI: 10.3390/ijms25116109.
Systemic cellular migration: The forces driving the directed locomotion movement of cells.
De la Fuente I, Carrasco-Pujante J, Camino-Pontes B, Fedetz M, Bringas C, Perez-Samartin A
PNAS Nexus. 2024; 3(5):pgae171.
PMID: 38706727
PMC: 11067954.
DOI: 10.1093/pnasnexus/pgae171.
Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches.
Tripathy D, Panda L, Biswal S, Barhwal K
Front Pharmacol. 2024; 15:1355242.
PMID: 38523646
PMC: 10957596.
DOI: 10.3389/fphar.2024.1355242.
The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential.
Wu K, Huang D, Huang X
Front Cell Dev Biol. 2023; 11:1321151.
PMID: 38078001
PMC: 10701534.
DOI: 10.3389/fcell.2023.1321151.
Repurposing Synthetic Congeners of a Natural Product Aurone Unveils a Lead Antitumor Agent Inhibiting Folded P-Loop Conformation of MET Receptor Tyrosine Kinase.
Hassan A, Wang C, Lee C, Jeon H, Choi Y, Moon S
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004462
PMC: 10675456.
DOI: 10.3390/ph16111597.
An Observatory for the Oncogene: A Guide for Targeted Therapies.
Altintas D, Comoglio P
Cancers (Basel). 2023; 15(18).
PMID: 37760640
PMC: 10526818.
DOI: 10.3390/cancers15184672.
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies.
He K, Wang Z, Luo M, Li B, Ding N, Li L
J Transl Med. 2023; 21(1):612.
PMID: 37689664
PMC: 10493031.
DOI: 10.1186/s12967-023-04460-5.
Anabolic phenotype in cartilage-specific mitogen-inducible gene-6 knockout mice is independent of transforming growth factor-α.
Hadzic E, To B, Pest M, Qin L, Beier F
Osteoarthr Cartil Open. 2023; 5(3):100387.
PMID: 37547183
PMC: 10400912.
DOI: 10.1016/j.ocarto.2023.100387.
The Treatment of a New Entity in Advanced Non-small Cell Lung Cancer: MET Exon 14 Skipping Mutation.
Rocco D, Della Gravara L, Palazzolo G, Gridelli C
Curr Med Chem. 2023; 31(21):3043-3056.
PMID: 37534484
DOI: 10.2174/0929867331666230803094432.
differentiated human CD4 T cells produce hepatocyte growth factor.
Ford S, Buus T, Nastasi C, Geisler C, Bonefeld C, Odum N
Front Immunol. 2023; 14:1210836.
PMID: 37520551
PMC: 10374024.
DOI: 10.3389/fimmu.2023.1210836.
Genomic and pathogenicity islands of -overview of selected aspects.
Wiktorczyk-Kapischke N, Skowron K, Walecka-Zacharska E
Front Mol Biosci. 2023; 10:1161486.
PMID: 37388250
PMC: 10300472.
DOI: 10.3389/fmolb.2023.1161486.
The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update.
Tiuca R, Tiuca O, Pascanu I
Biomedicines. 2023; 11(4).
PMID: 37189693
PMC: 10135953.
DOI: 10.3390/biomedicines11041075.
Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells.
Erzurumlu Y, Catakli D, Kubra Dogan H
J Nat Med. 2023; 77(3):572-583.
PMID: 37130999
DOI: 10.1007/s11418-023-01701-1.
Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2.
Chen K, Gong W, Huang J, Yoshimura T, Wang J
Int Immunopharmacol. 2023; 118:110052.
PMID: 37003185
PMC: 10149111.
DOI: 10.1016/j.intimp.2023.110052.
Hepatocyte growth factor ameliorates dextran sodium sulfate‑induced colitis in a mouse model by altering the phenotype of intestinal macrophages.
Fujino Y, Kanmura S, Morinaga Y, Kojima I, Maeda N, Tanaka A
Mol Med Rep. 2023; 27(3).
PMID: 36799161
PMC: 9942250.
DOI: 10.3892/mmr.2023.12957.